Smith & Nephew (SNN) Curent Deferred Tax Liability (2014 - 2015)
Smith & Nephew (SNN) reported Curent Deferred Tax Liability of $26.8 million for Q4 2015, down 10.07% on a YoY basis from $29.8 million in Q4 2014, and down 4.96% quarter-over-quarter from $28.2 million in Q2 2015.
Smith & Nephew (SNN) Curent Deferred Tax Liability (2014 - 2015) Analysis & Trends
Smith & Nephew has reported Curent Deferred Tax Liability for 2 years, with the latest figure at $26.8 million in Q4 2015.
- For the quarter ending Q4 2015, Curent Deferred Tax Liability fell 10.07% year-over-year to $26.8 million; the trailing twelve-month figure through Dec 2015 stood at $26.8 million (down 10.07% YoY), and the FY2015 full-year result was $26.8 million, down 10.07% from the prior year.
- Curent Deferred Tax Liability for Q4 2015 stood at $26.8 million, down from $28.2 million in the prior quarter.
- The five-year high for Curent Deferred Tax Liability was $29.8 million in Q4 2014, with the low at $26.8 million in Q4 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Curent Deferred Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Smith & Nephew | 5.27 Bn | 4.69 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 26.80 Mn |
| Dec 31, 2015 | 26.80 Mn |
| Jun 30, 2015 | 28.20 Mn |
| Jun 30, 2015 | 28.20 Mn |
| Dec 31, 2014 | 29.80 Mn |
| Dec 31, 2014 | 29.80 Mn |